Cell Death Differ (2016) 23:36979
Clinical Trials of IN Administration of Peptides for CNS Therapy Although N-to-B delivery has been well established in clinical trials, improved N-to-B delivery systems have yet to be associated with approved products [6]
Moreover, the receptor controls the expression of the AR-dependent KGA isoform of GLS, resulting in increased TCA cycle metabolite -ketoglutarate, a key intermediate of glutaminolysis [108,121]
[DOI] [PubMed] [Google Scholar] 196.Paulsen B., Velasco S., Kedaigle A.J., Pigoni M., Quadrato G., Deo A.J., Adiconis X., Uzquiano A., Sartore R., Yang S.M., et al
The process according to claim 9, 10 or 1 1 , for the preparation of glutathione in alpha crystalline form containing less than 10% of amorphous or other crystalline forms
Emerg Med J 25:3337 Stambolija V, Stambolija TP, Holjevac JK, Murselovic T, Radonic J, Duzel V, Duplancic B, Uzun S, Zivanovic-Posilovic G, Kolenc D, Drmic D (2016) BPC 157: the counteraction of succinylcholine, hyperkalemia, and arrhythmias
